课题基金 / 基金详情

Engagement in opioid agonist therapy and risk for repeat overdose in people with and without HIV who experienced a nonfatal opioid overdose: providing insight to improve clinical care

Engagement in opioid agonist therapy and risk for repeat overdose in people with and without HIV who experienced a nonfatal opioid overdose: providing insight to improve clinical care
经历过非致命性阿片类药物过量的艾滋病毒感染者和非艾滋病毒患者接受阿片类激动剂治疗以及重复用药过量的风险：提供见解以改善临床护理
批准号：
484635
负责人：
Kooij Katherine
金额：
$7.9万
依托单位：
B.C. Centre for Excellence in HIV/AIDS (Vancouver)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2025-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=484635&lang=en
关键词：
Administrative Health Data Cohort Study Drug Toxicity Engagement In Care Opioid Agonist Therapy Opioid Overdose Opioid Use Disorder People Who Use Drugs People With Hiv Primary Care

项目摘要

项目成果

Kooij Katherine的其他基金

相似基金

相关文献

中文摘要
翻译
持续的药物毒性和过量危机对不列颠哥伦比亚省（BC）人口的健康产生了破坏性影响。阿片类激动剂治疗（OAT）有效地降低了阿片类药物过量的风险，但并不是所有阿片类药物使用障碍的人（OAT）都能有效地降低阿片类药物过量的风险。
英文摘要
The ongoing drug toxicity and overdose crisis has devastating effects on the health of the population in British Columbia (BC). Opioid agonist therapy (OAT) effectively reduces the risk for an opioid overdose, but not everyone with opioid use disorder (OU
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
not applicable
Preventing long term adverse outcomes of nonfatal drug overdose in people living with HIV: providing insight in the risk for repeat overdose, all-cause mortality, and HIV treatment failure after a hospitalization for a nonfatal drug overdose, and formulat
海外基金